Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global DNA Repair Drugs Market Growth 2022-2028

  • LP 4844150
  • 110 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of DNA Repair Drugs will have significant change from previous year. According to our (LP Information) latest study, the global DNA Repair Drugs market size is USD million in 2022 from USD 580.7 million in 2021, with a change of % between 2021 and 2022. The global DNA Repair Drugs market size will reach USD 1972.6 million in 2028, growing at a CAGR of 19.1% over the analysis period.

The United States DNA Repair Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global DNA Repair Drugs market, reaching US$ million by the year 2028. As for the Europe DNA Repair Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main DNA Repair Drugs players cover 4SC AG, ARCAGY/ GINECO GROUP, Bristol Myers Squibb, and British Columbia Cancer Agency, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of DNA Repair Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

PARP Inhibitors

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Oncological

Stroke

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

4SC AG

ARCAGY/ GINECO GROUP

Bristol Myers Squibb

British Columbia Cancer Agency

Cambridge University Hospitals NHS Foundation Trust

Genentech

Georgetown University

German Breast Group

GlaxoSmithKline

Jiangsu Hengrui Medicine

Johnson & Johnson

Jonsson Comprehensive Cancer Center

Karyopharm Therapeutics

KuDOS Pharmaceuticals

National Health Service

National Institutes of Health

Tesaro

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global DNA Repair Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for DNA Repair Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for DNA Repair Drugs by Country/Region, 2017, 2022 & 2028

2.2 DNA Repair Drugs Segment by Type

2.2.1 PARP Inhibitors

2.2.2 Other

2.3 DNA Repair Drugs Sales by Type

2.3.1 Global DNA Repair Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global DNA Repair Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global DNA Repair Drugs Sale Price by Type (2017-2022)

2.4 DNA Repair Drugs Segment by Application

2.4.1 Oncological

2.4.2 Stroke

2.5 DNA Repair Drugs Sales by Application

2.5.1 Global DNA Repair Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global DNA Repair Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global DNA Repair Drugs Sale Price by Application (2017-2022)

3 Global DNA Repair Drugs by Company

3.1 Global DNA Repair Drugs Breakdown Data by Company

3.1.1 Global DNA Repair Drugs Annual Sales by Company (2020-2022)

3.1.2 Global DNA Repair Drugs Sales Market Share by Company (2020-2022)

3.2 Global DNA Repair Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global DNA Repair Drugs Revenue by Company (2020-2022)

3.2.2 Global DNA Repair Drugs Revenue Market Share by Company (2020-2022)

3.3 Global DNA Repair Drugs Sale Price by Company

3.4 Key Manufacturers DNA Repair Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers DNA Repair Drugs Product Location Distribution

3.4.2 Players DNA Repair Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for DNA Repair Drugs by Geographic Region

4.1 World Historic DNA Repair Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global DNA Repair Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global DNA Repair Drugs Annual Revenue by Geographic Region

4.2 World Historic DNA Repair Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global DNA Repair Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global DNA Repair Drugs Annual Revenue by Country/Region

4.3 Americas DNA Repair Drugs Sales Growth

4.4 APAC DNA Repair Drugs Sales Growth

4.5 Europe DNA Repair Drugs Sales Growth

4.6 Middle East & Africa DNA Repair Drugs Sales Growth

5 Americas

5.1 Americas DNA Repair Drugs Sales by Country

5.1.1 Americas DNA Repair Drugs Sales by Country (2017-2022)

5.1.2 Americas DNA Repair Drugs Revenue by Country (2017-2022)

5.2 Americas DNA Repair Drugs Sales by Type

5.3 Americas DNA Repair Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC DNA Repair Drugs Sales by Region

6.1.1 APAC DNA Repair Drugs Sales by Region (2017-2022)

6.1.2 APAC DNA Repair Drugs Revenue by Region (2017-2022)

6.2 APAC DNA Repair Drugs Sales by Type

6.3 APAC DNA Repair Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe DNA Repair Drugs by Country

7.1.1 Europe DNA Repair Drugs Sales by Country (2017-2022)

7.1.2 Europe DNA Repair Drugs Revenue by Country (2017-2022)

7.2 Europe DNA Repair Drugs Sales by Type

7.3 Europe DNA Repair Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa DNA Repair Drugs by Country

8.1.1 Middle East & Africa DNA Repair Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa DNA Repair Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa DNA Repair Drugs Sales by Type

8.3 Middle East & Africa DNA Repair Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of DNA Repair Drugs

10.3 Manufacturing Process Analysis of DNA Repair Drugs

10.4 Industry Chain Structure of DNA Repair Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 DNA Repair Drugs Distributors

11.3 DNA Repair Drugs Customer

12 World Forecast Review for DNA Repair Drugs by Geographic Region

12.1 Global DNA Repair Drugs Market Size Forecast by Region

12.1.1 Global DNA Repair Drugs Forecast by Region (2023-2028)

12.1.2 Global DNA Repair Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global DNA Repair Drugs Forecast by Type

12.7 Global DNA Repair Drugs Forecast by Application

13 Key Players Analysis

13.1 4SC AG

13.1.1 4SC AG Company Information

13.1.2 4SC AG DNA Repair Drugs Product Offered

13.1.3 4SC AG DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 4SC AG Main Business Overview

13.1.5 4SC AG Latest Developments

13.2 ARCAGY/ GINECO GROUP

13.2.1 ARCAGY/ GINECO GROUP Company Information

13.2.2 ARCAGY/ GINECO GROUP DNA Repair Drugs Product Offered

13.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 ARCAGY/ GINECO GROUP Main Business Overview

13.2.5 ARCAGY/ GINECO GROUP Latest Developments

13.3 Bristol Myers Squibb

13.3.1 Bristol Myers Squibb Company Information

13.3.2 Bristol Myers Squibb DNA Repair Drugs Product Offered

13.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bristol Myers Squibb Main Business Overview

13.3.5 Bristol Myers Squibb Latest Developments

13.4 British Columbia Cancer Agency

13.4.1 British Columbia Cancer Agency Company Information

13.4.2 British Columbia Cancer Agency DNA Repair Drugs Product Offered

13.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 British Columbia Cancer Agency Main Business Overview

13.4.5 British Columbia Cancer Agency Latest Developments

13.5 Cambridge University Hospitals NHS Foundation Trust

13.5.1 Cambridge University Hospitals NHS Foundation Trust Company Information

13.5.2 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Offered

13.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Cambridge University Hospitals NHS Foundation Trust Main Business Overview

13.5.5 Cambridge University Hospitals NHS Foundation Trust Latest Developments

13.6 Genentech

13.6.1 Genentech Company Information

13.6.2 Genentech DNA Repair Drugs Product Offered

13.6.3 Genentech DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Genentech Main Business Overview

13.6.5 Genentech Latest Developments

13.7 Georgetown University

13.7.1 Georgetown University Company Information

13.7.2 Georgetown University DNA Repair Drugs Product Offered

13.7.3 Georgetown University DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Georgetown University Main Business Overview

13.7.5 Georgetown University Latest Developments

13.8 German Breast Group

13.8.1 German Breast Group Company Information

13.8.2 German Breast Group DNA Repair Drugs Product Offered

13.8.3 German Breast Group DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 German Breast Group Main Business Overview

13.8.5 German Breast Group Latest Developments

13.9 GlaxoSmithKline

13.9.1 GlaxoSmithKline Company Information

13.9.2 GlaxoSmithKline DNA Repair Drugs Product Offered

13.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 GlaxoSmithKline Main Business Overview

13.9.5 GlaxoSmithKline Latest Developments

13.10 Jiangsu Hengrui Medicine

13.10.1 Jiangsu Hengrui Medicine Company Information

13.10.2 Jiangsu Hengrui Medicine DNA Repair Drugs Product Offered

13.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Jiangsu Hengrui Medicine Main Business Overview

13.10.5 Jiangsu Hengrui Medicine Latest Developments

13.11 Johnson & Johnson

13.11.1 Johnson & Johnson Company Information

13.11.2 Johnson & Johnson DNA Repair Drugs Product Offered

13.11.3 Johnson & Johnson DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Johnson & Johnson Main Business Overview

13.11.5 Johnson & Johnson Latest Developments

13.12 Jonsson Comprehensive Cancer Center

13.12.1 Jonsson Comprehensive Cancer Center Company Information

13.12.2 Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Offered

13.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Jonsson Comprehensive Cancer Center Main Business Overview

13.12.5 Jonsson Comprehensive Cancer Center Latest Developments

13.13 Karyopharm Therapeutics

13.13.1 Karyopharm Therapeutics Company Information

13.13.2 Karyopharm Therapeutics DNA Repair Drugs Product Offered

13.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Karyopharm Therapeutics Main Business Overview

13.13.5 Karyopharm Therapeutics Latest Developments

13.14 KuDOS Pharmaceuticals

13.14.1 KuDOS Pharmaceuticals Company Information

13.14.2 KuDOS Pharmaceuticals DNA Repair Drugs Product Offered

13.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 KuDOS Pharmaceuticals Main Business Overview

13.14.5 KuDOS Pharmaceuticals Latest Developments

13.15 National Health Service

13.15.1 National Health Service Company Information

13.15.2 National Health Service DNA Repair Drugs Product Offered

13.15.3 National Health Service DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 National Health Service Main Business Overview

13.15.5 National Health Service Latest Developments

13.16 National Institutes of Health

13.16.1 National Institutes of Health Company Information

13.16.2 National Institutes of Health DNA Repair Drugs Product Offered

13.16.3 National Institutes of Health DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 National Institutes of Health Main Business Overview

13.16.5 National Institutes of Health Latest Developments

13.17 Tesaro

13.17.1 Tesaro Company Information

13.17.2 Tesaro DNA Repair Drugs Product Offered

13.17.3 Tesaro DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Tesaro Main Business Overview

13.17.5 Tesaro Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. DNA Repair Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. DNA Repair Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of PARP Inhibitors

Table 4. Major Players of Other

Table 5. Global DNA Repair Drugs Sales by Type (2017-2022) & (K Units)

Table 6. Global DNA Repair Drugs Sales Market Share by Type (2017-2022)

Table 7. Global DNA Repair Drugs Revenue by Type (2017-2022) & ($ million)

Table 8. Global DNA Repair Drugs Revenue Market Share by Type (2017-2022)

Table 9. Global DNA Repair Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global DNA Repair Drugs Sales by Application (2017-2022) & (K Units)

Table 11. Global DNA Repair Drugs Sales Market Share by Application (2017-2022)

Table 12. Global DNA Repair Drugs Revenue by Application (2017-2022)

Table 13. Global DNA Repair Drugs Revenue Market Share by Application (2017-2022)

Table 14. Global DNA Repair Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global DNA Repair Drugs Sales by Company (2020-2022) & (K Units)

Table 16. Global DNA Repair Drugs Sales Market Share by Company (2020-2022)

Table 17. Global DNA Repair Drugs Revenue by Company (2020-2022) ($ Millions)

Table 18. Global DNA Repair Drugs Revenue Market Share by Company (2020-2022)

Table 19. Global DNA Repair Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers DNA Repair Drugs Producing Area Distribution and Sales Area

Table 21. Players DNA Repair Drugs Products Offered

Table 22. DNA Repair Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global DNA Repair Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global DNA Repair Drugs Sales Market Share Geographic Region (2017-2022)

Table 27. Global DNA Repair Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global DNA Repair Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global DNA Repair Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global DNA Repair Drugs Sales Market Share by Country/Region (2017-2022)

Table 31. Global DNA Repair Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global DNA Repair Drugs Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas DNA Repair Drugs Sales by Country (2017-2022) & (K Units)

Table 34. Americas DNA Repair Drugs Sales Market Share by Country (2017-2022)

Table 35. Americas DNA Repair Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas DNA Repair Drugs Revenue Market Share by Country (2017-2022)

Table 37. Americas DNA Repair Drugs Sales by Type (2017-2022) & (K Units)

Table 38. Americas DNA Repair Drugs Sales Market Share by Type (2017-2022)

Table 39. Americas DNA Repair Drugs Sales by Application (2017-2022) & (K Units)

Table 40. Americas DNA Repair Drugs Sales Market Share by Application (2017-2022)

Table 41. APAC DNA Repair Drugs Sales by Region (2017-2022) & (K Units)

Table 42. APAC DNA Repair Drugs Sales Market Share by Region (2017-2022)

Table 43. APAC DNA Repair Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC DNA Repair Drugs Revenue Market Share by Region (2017-2022)

Table 45. APAC DNA Repair Drugs Sales by Type (2017-2022) & (K Units)

Table 46. APAC DNA Repair Drugs Sales Market Share by Type (2017-2022)

Table 47. APAC DNA Repair Drugs Sales by Application (2017-2022) & (K Units)

Table 48. APAC DNA Repair Drugs Sales Market Share by Application (2017-2022)

Table 49. Europe DNA Repair Drugs Sales by Country (2017-2022) & (K Units)

Table 50. Europe DNA Repair Drugs Sales Market Share by Country (2017-2022)

Table 51. Europe DNA Repair Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe DNA Repair Drugs Revenue Market Share by Country (2017-2022)

Table 53. Europe DNA Repair Drugs Sales by Type (2017-2022) & (K Units)

Table 54. Europe DNA Repair Drugs Sales Market Share by Type (2017-2022)

Table 55. Europe DNA Repair Drugs Sales by Application (2017-2022) & (K Units)

Table 56. Europe DNA Repair Drugs Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa DNA Repair Drugs Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa DNA Repair Drugs Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa DNA Repair Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa DNA Repair Drugs Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa DNA Repair Drugs Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa DNA Repair Drugs Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa DNA Repair Drugs Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa DNA Repair Drugs Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of DNA Repair Drugs

Table 66. Key Market Challenges & Risks of DNA Repair Drugs

Table 67. Key Industry Trends of DNA Repair Drugs

Table 68. DNA Repair Drugs Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. DNA Repair Drugs Distributors List

Table 71. DNA Repair Drugs Customer List

Table 72. Global DNA Repair Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global DNA Repair Drugs Sales Market Forecast by Region

Table 74. Global DNA Repair Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global DNA Repair Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas DNA Repair Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas DNA Repair Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC DNA Repair Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC DNA Repair Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe DNA Repair Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe DNA Repair Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa DNA Repair Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa DNA Repair Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global DNA Repair Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global DNA Repair Drugs Sales Market Share Forecast by Type (2023-2028)

Table 86. Global DNA Repair Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global DNA Repair Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global DNA Repair Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global DNA Repair Drugs Sales Market Share Forecast by Application (2023-2028)

Table 90. Global DNA Repair Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global DNA Repair Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 92. 4SC AG Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. 4SC AG DNA Repair Drugs Product Offered

Table 94. 4SC AG DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. 4SC AG Main Business

Table 96. 4SC AG Latest Developments

Table 97. ARCAGY/ GINECO GROUP Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. ARCAGY/ GINECO GROUP DNA Repair Drugs Product Offered

Table 99. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. ARCAGY/ GINECO GROUP Main Business

Table 101. ARCAGY/ GINECO GROUP Latest Developments

Table 102. Bristol Myers Squibb Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 103. Bristol Myers Squibb DNA Repair Drugs Product Offered

Table 104. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Bristol Myers Squibb Main Business

Table 106. Bristol Myers Squibb Latest Developments

Table 107. British Columbia Cancer Agency Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 108. British Columbia Cancer Agency DNA Repair Drugs Product Offered

Table 109. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. British Columbia Cancer Agency Main Business

Table 111. British Columbia Cancer Agency Latest Developments

Table 112. Cambridge University Hospitals NHS Foundation Trust Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 113. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Offered

Table 114. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Cambridge University Hospitals NHS Foundation Trust Main Business

Table 116. Cambridge University Hospitals NHS Foundation Trust Latest Developments

Table 117. Genentech Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 118. Genentech DNA Repair Drugs Product Offered

Table 119. Genentech DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Genentech Main Business

Table 121. Genentech Latest Developments

Table 122. Georgetown University Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 123. Georgetown University DNA Repair Drugs Product Offered

Table 124. Georgetown University DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Georgetown University Main Business

Table 126. Georgetown University Latest Developments

Table 127. German Breast Group Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 128. German Breast Group DNA Repair Drugs Product Offered

Table 129. German Breast Group DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. German Breast Group Main Business

Table 131. German Breast Group Latest Developments

Table 132. GlaxoSmithKline Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 133. GlaxoSmithKline DNA Repair Drugs Product Offered

Table 134. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. GlaxoSmithKline Main Business

Table 136. GlaxoSmithKline Latest Developments

Table 137. Jiangsu Hengrui Medicine Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 138. Jiangsu Hengrui Medicine DNA Repair Drugs Product Offered

Table 139. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Jiangsu Hengrui Medicine Main Business

Table 141. Jiangsu Hengrui Medicine Latest Developments

Table 142. Johnson & Johnson Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 143. Johnson & Johnson DNA Repair Drugs Product Offered

Table 144. Johnson & Johnson DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. Johnson & Johnson Main Business

Table 146. Johnson & Johnson Latest Developments

Table 147. Jonsson Comprehensive Cancer Center Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 148. Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Offered

Table 149. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. Jonsson Comprehensive Cancer Center Main Business

Table 151. Jonsson Comprehensive Cancer Center Latest Developments

Table 152. Karyopharm Therapeutics Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 153. Karyopharm Therapeutics DNA Repair Drugs Product Offered

Table 154. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 155. Karyopharm Therapeutics Main Business

Table 156. Karyopharm Therapeutics Latest Developments

Table 157. KuDOS Pharmaceuticals Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 158. KuDOS Pharmaceuticals DNA Repair Drugs Product Offered

Table 159. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 160. KuDOS Pharmaceuticals Main Business

Table 161. KuDOS Pharmaceuticals Latest Developments

Table 162. National Health Service Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 163. National Health Service DNA Repair Drugs Product Offered

Table 164. National Health Service DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 165. National Health Service Main Business

Table 166. National Health Service Latest Developments

Table 167. National Institutes of Health Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 168. National Institutes of Health DNA Repair Drugs Product Offered

Table 169. National Institutes of Health DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 170. National Institutes of Health Main Business

Table 171. National Institutes of Health Latest Developments

Table 172. Tesaro Basic Information, DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors

Table 173. Tesaro DNA Repair Drugs Product Offered

Table 174. Tesaro DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 175. Tesaro Main Business

Table 176. Tesaro Latest Developments

List of Figures

Figure 1. Picture of DNA Repair Drugs

Figure 2. DNA Repair Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global DNA Repair Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global DNA Repair Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. DNA Repair Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of PARP Inhibitors

Figure 10. Product Picture of Other

Figure 11. Global DNA Repair Drugs Sales Market Share by Type in 2021

Figure 12. Global DNA Repair Drugs Revenue Market Share by Type (2017-2022)

Figure 13. DNA Repair Drugs Consumed in Oncological

Figure 14. Global DNA Repair Drugs Market: Oncological (2017-2022) & (K Units)

Figure 15. DNA Repair Drugs Consumed in Stroke

Figure 16. Global DNA Repair Drugs Market: Stroke (2017-2022) & (K Units)

Figure 17. Global DNA Repair Drugs Sales Market Share by Application (2017-2022)

Figure 18. Global DNA Repair Drugs Revenue Market Share by Application in 2021

Figure 19. DNA Repair Drugs Revenue Market by Company in 2021 ($ Million)

Figure 20. Global DNA Repair Drugs Revenue Market Share by Company in 2021

Figure 21. Global DNA Repair Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global DNA Repair Drugs Revenue Market Share by Geographic Region in 2021

Figure 23. Global DNA Repair Drugs Sales Market Share by Region (2017-2022)

Figure 24. Global DNA Repair Drugs Revenue Market Share by Country/Region in 2021

Figure 25. Americas DNA Repair Drugs Sales 2017-2022 (K Units)

Figure 26. Americas DNA Repair Drugs Revenue 2017-2022 ($ Millions)

Figure 27. APAC DNA Repair Drugs Sales 2017-2022 (K Units)

Figure 28. APAC DNA Repair Drugs Revenue 2017-2022 ($ Millions)

Figure 29. Europe DNA Repair Drugs Sales 2017-2022 (K Units)

Figure 30. Europe DNA Repair Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa DNA Repair Drugs Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa DNA Repair Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Americas DNA Repair Drugs Sales Market Share by Country in 2021

Figure 34. Americas DNA Repair Drugs Revenue Market Share by Country in 2021

Figure 35. United States DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC DNA Repair Drugs Sales Market Share by Region in 2021

Figure 40. APAC DNA Repair Drugs Revenue Market Share by Regions in 2021

Figure 41. China DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. India DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe DNA Repair Drugs Sales Market Share by Country in 2021

Figure 48. Europe DNA Repair Drugs Revenue Market Share by Country in 2021

Figure 49. Germany DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. France DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa DNA Repair Drugs Sales Market Share by Country in 2021

Figure 55. Middle East & Africa DNA Repair Drugs Revenue Market Share by Country in 2021

Figure 56. Egypt DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country DNA Repair Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of DNA Repair Drugs in 2021

Figure 62. Manufacturing Process Analysis of DNA Repair Drugs

Figure 63. Industry Chain Structure of DNA Repair Drugs

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390